美国人群对赴日本脑炎流行国家旅行时接种日本脑炎疫苗价值的认知调查
该调查通过电子问卷向美国成年人呈现赴日本脑炎流行国家旅行的假设场景及疫苗特征,询问接种意愿。10904人中6384人(59%)完成问题,人群估计32%可能接种、42%不太可能接种、26%不确定。可能接种者重视疾病风险与严重性及疫苗安全性;不太可能接种者最看重费用、疾病风险和严重副作用可能性。
要点
- 10904名美国成年人中6384人(59%)完成问卷,人群估计32%可能接种、42%不太可能、26%不确定。
- 可能接种者认为疾病风险与严重性及疫苗安全性是重要因素。
- 不太可能接种者将费用、疾病风险和严重副作用可能性列为最高因素。
核心结论
- 人群对日本脑炎疾病风险和疫苗接种价值的认知存在异质性。
研究设计与样本
- 在美国成年人中开展的电子问卷横断面调查,共10904人受邀,6384人(59%)完成问题。
主要发现
- 人群估计32%可能接种日本脑炎疫苗、42%不太可能接种、26%不确定。
- 可能接种者中,重要因素包括疾病风险与严重性以及疫苗安全性。
- 不太可能接种者中,费用、疾病风险和严重副作用可能性排名最高。
关键数值与推荐
- 美国日本脑炎疫苗2剂系列费用为500至600美元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Japanese encephalitis (JE) is a rare but potentially severe disease among travelers. JE vaccine in the United States costs $500-$600 for a 2-dose series and is safe and effective but rare serious adverse events can occur. Our survey investigated likelihood of vaccine receipt for travel. METHODS: An electronically-administered survey was conducted among U.S. adults. Participants were presented a hypothetical scenario on travel to a JE-endemic country and JE vaccine characteristics and responded on likelihood of vaccination. RESULTS: Overall, 6384 (59%) of 10,904 persons completed the questions. Population estimates indicated 32% would be likely and 42% were unlikely to be vaccinated, and 26% were unsure. Among those likely to get vaccinated, important factors were disease risk and severity, and vaccine safety. Among those unlikely, cost, disease risk, and possibility of serious side effects ranked highest. CONCLUSIONS: There is population heterogeneity in perception of JE disease risk and value of vaccination.
引用
- Hills SL, Fischer M, Biggerstaff BJ, et al. Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries. Vaccine. 2020. PMID: 31992482. doi:10.1016/j.vaccine.2020.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。